• Explore /
  • Poster
  • / Phase II study of individualized adaptive stereotactic body radiotherapy (SBRT) for patients at high risk for liver damage.

Phase II study of individualized adaptive stereotactic body radiotherapy (SBRT) for patients at high risk for liver damage.

Abstract Poster

Authors

null

Mary Uan-Sian Feng

Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI

Mary Uan-Sian Feng , Krithika Suresh , Matthew J Schipper , Latifa Bazzi , Edgar Ben-Josef , Martha Matuszak , Neehar Parikh , Theodore Hobart Welling III, Randall K Ten Haken , Theodore Steven Lawrence

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 424)

DOI

10.1200/jco.2016.34.4_suppl.424

Abstract #

424

Poster Bd #

L18

Abstract Disclosures

Similar Posters

Poster

2017 Gastrointestinal Cancers Symposium

Stereotactic body radiotherapy for hepatocellular carcinoma in the setting of poor liver function: A case series.

Stereotactic body radiotherapy for hepatocellular carcinoma in the setting of poor liver function: A case series.

First Author: Vladimir Valakh

First Author: Yixing Chen

First Author: Jiayu Duan

First Author: Jonathan David Tward